urea has been researched along with Pulmonary Hypertension in 13 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The use of landiolol hydrochloride for HR control of non-arrhythmic tachycardia in critically ill infants is well tolerated." | 8.31 | Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension. ( Ackerl, J; Dresbach, T; Kipfmueller, F; Monno, P; Mueller, A; Schmitt, J; Schroeder, L; Shatilova, O; Unger, M, 2023) |
| "The use of landiolol hydrochloride for HR control of non-arrhythmic tachycardia in critically ill infants is well tolerated." | 4.31 | Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension. ( Ackerl, J; Dresbach, T; Kipfmueller, F; Monno, P; Mueller, A; Schmitt, J; Schroeder, L; Shatilova, O; Unger, M, 2023) |
| " Pathway analysis demonstrated that methionine metabolism and urea cycle metabolism were the most significant pathway involved in the pathogenesis of hypoxia-induced PH model and MCT-induced model, respectively, and both of them were also observed in the dysregulated pathways in IPAH patients." | 3.91 | Circulating Plasma Metabolomic Profiles Differentiate Rodent Models of Pulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension Patients. ( Guo, SS; Han, ZY; He, YY; Jing, ZC; Lin, JH; Pang, XB; Wang, Y; Wang, Z; Xie, XM; Yan, Y; Ye, J; Zhang, JL; Zhao, JH, 2019) |
| "In asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis, increased arginase activity in the airways may contribute to obstruction and hyperresponsiveness of the airways by inducing a reduction in the production of bronchodilatory nitric oxide (NO) that results from its competition with constitutive (cNOS) and inducible (iNOS) NO synthases for their common substrate." | 2.44 | Arginase and pulmonary diseases. ( Maarsingh, H; Meurs, H; Pera, T, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Schroeder, L | 1 |
| Monno, P | 1 |
| Unger, M | 1 |
| Ackerl, J | 1 |
| Shatilova, O | 1 |
| Schmitt, J | 1 |
| Dresbach, T | 1 |
| Mueller, A | 1 |
| Kipfmueller, F | 1 |
| Zheng, HK | 1 |
| Zhao, JH | 2 |
| Yan, Y | 2 |
| Lian, TY | 1 |
| Ye, J | 2 |
| Wang, XJ | 1 |
| Wang, Z | 2 |
| Jing, ZC | 2 |
| He, YY | 2 |
| Yang, P | 1 |
| Guo, SS | 1 |
| Zhang, JL | 1 |
| Wang, Y | 1 |
| Pang, XB | 1 |
| Xie, XM | 1 |
| Lin, JH | 1 |
| Han, ZY | 1 |
| Pehlivan, Y | 2 |
| Dokuyucu, R | 1 |
| Demir, T | 2 |
| Kaplan, DS | 2 |
| Koc, I | 1 |
| Orkmez, M | 2 |
| Turkbeyler, IH | 2 |
| Ceribasi, AO | 2 |
| Tutar, E | 2 |
| Taysi, S | 2 |
| Kisacik, B | 2 |
| Onat, AM | 2 |
| West, JD | 1 |
| Carrier, EJ | 1 |
| Bloodworth, NC | 1 |
| Schroer, AK | 1 |
| Chen, P | 1 |
| Ryzhova, LM | 1 |
| Gladson, S | 1 |
| Shay, S | 1 |
| Hutcheson, JD | 1 |
| Merryman, WD | 1 |
| Mazzotta, E | 1 |
| Guglielmini, C | 1 |
| Menciotti, G | 1 |
| Contiero, B | 1 |
| Baron Toaldo, M | 1 |
| Berlanda, M | 1 |
| Poser, H | 1 |
| Trittmann, JK | 1 |
| Jin, Y | 1 |
| Chicoine, LG | 1 |
| Liu, Y | 1 |
| Chen, B | 1 |
| Nelin, LD | 1 |
| Simpson, CM | 1 |
| Smolich, JJ | 1 |
| Shekerdemian, LS | 1 |
| Penny, DJ | 1 |
| Sayarlioglu, M | 1 |
| WEST, JB | 1 |
| DOLLERY, CT | 1 |
| HEARD, BE | 1 |
| Rosenzweig, EB | 1 |
| Barst, RJ | 1 |
| Esposito, C | 1 |
| De Mauri, A | 1 |
| Vitulo, P | 1 |
| Oggionni, T | 1 |
| Cornacchia, F | 1 |
| Valentino, R | 1 |
| Grosjean, F | 1 |
| Torreggiani, M | 1 |
| Dal Canton, A | 1 |
| Maarsingh, H | 1 |
| Pera, T | 1 |
| Meurs, H | 1 |
2 reviews available for urea and Pulmonary Hypertension
| Article | Year |
|---|---|
Idiopathic pulmonary arterial hypertension in children.
Topics: Anticoagulants; Antihypertensive Agents; Calcium Channel Blockers; Carbamide Peroxide; Child; Drug C | 2005 |
Arginase and pulmonary diseases.
Topics: Animals; Arginase; Arginine; Asthma; Cystic Fibrosis; Disease Models, Animal; Humans; Hypertension, | 2008 |
11 other studies available for urea and Pulmonary Hypertension
| Article | Year |
|---|---|
Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension.
Topics: Child; Critical Illness; Female; Heart Rate; Humans; Hypertension, Pulmonary; Infant; Infant, Newbor | 2023 |
Metabolic reprogramming of the urea cycle pathway in experimental pulmonary arterial hypertension rats induced by monocrotaline.
Topics: Animals; Hypertension, Pulmonary; Male; Metabolomics; Monocrotaline; Random Allocation; Rats; Rats, | 2018 |
Circulating Plasma Metabolomic Profiles Differentiate Rodent Models of Pulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension Patients.
Topics: Adult; Animals; Biomarkers; Case-Control Studies; Disease Models, Animal; Familial Primary Pulmonary | 2019 |
Palosuran treatment effective as bosentan in the treatment model of pulmonary arterial hypertension.
Topics: Animals; Arterial Pressure; Bosentan; Disease Models, Animal; Endothelin Receptor Antagonists; Endot | 2014 |
Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension.
Topics: Animals; Bone Morphogenetic Protein Receptors, Type II; Cell Movement; Cytoskeletal Proteins; Gene E | 2016 |
Red Blood Cell Distribution Width, Hematology, and Serum Biochemistry in Dogs with Echocardiographically Estimated Precapillary and Postcapillary Pulmonary Arterial Hypertension.
Topics: Animals; Dog Diseases; Dogs; Echocardiography; Erythrocyte Indices; Female; Hematocrit; Hypertension | 2016 |
An arginase-1 SNP that protects against the development of pulmonary hypertension in bronchopulmonary dysplasia enhances NO-mediated apoptosis in lymphocytes.
Topics: Apoptosis; Arginase; Arginine; Bronchopulmonary Dysplasia; Caspase 3; Cohort Studies; Humans; Hypert | 2016 |
Urotensin-II contributes to pulmonary vasoconstriction in a perinatal model of persistent pulmonary hypertension of the newborn secondary to meconium aspiration syndrome.
Topics: Animals; Animals, Newborn; Blood Pressure; Cardiac Output; Disease Models, Animal; Endothelin-1; Fem | 2010 |
Urotensin inhibition with palosuran could be a promising alternative in pulmonary arterial hypertension.
Topics: Animals; Arterial Pressure; Arterioles; Endothelin-1; Familial Primary Pulmonary Hypertension; Hemod | 2013 |
INCREASED PULMONARY VASCULAR RESISTANCE IN THE DEPENDENT ZONE OF THE ISOLATED DOG LUNG CAUSED BY PERIVASCULAR EDEMA.
Topics: Chemotherapy, Cancer, Regional Perfusion; Dogs; Edema; Hypertension; Hypertension, Pulmonary; Lung; | 1965 |
Risk factors for chronic renal dysfunction in lung transplant recipients.
Topics: Adult; Age Factors; Blood Pressure; Comorbidity; Female; Humans; Hypertension, Pulmonary; Kidney Fai | 2007 |